Tarka tablets modified-release film-coated

País: Armènia

Idioma: anglès

Font: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

ingredients actius:

trandolapril, verapamil (verapamil hydrochloride)

Disponible des:

AbbVie Deutschland GmbH & Co. KG

Codi ATC:

C09BB10

Designació comuna internacional (DCI):

trandolapril, verapamil (verapamil hydrochloride)

Dosis:

2mg+ 180mg

formulario farmacéutico:

tablets modified-release film-coated

Unidades en paquete:

(28/2x14/) in blister

tipo de receta:

Prescription

Estat d'Autorització:

Registered

Data d'autorització:

2020-07-17

Fitxa tècnica

Trandolapril - Verapamil
SOLID 1000311530
v9.0
COMPANY CORE DATA
SHEET
TRANDOLAPRIL/VERAPAMIL
Date of approval: 24-Sep-2014
Date of previous approval: 14-Jan-2014
Abbott
Confidential information
1/28
This information is confidential
_NAME OF THE MEDICINAL PRODUCT_
Tarka 180 mg / 2 mg, modify-released, film-coated tablets.
Tarka 240 mg / 4 mg, modify-released, film-coated tablets.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Tarka is supplied as tablets or capsules containing immediate release
trandolapril and
sustained release verapamil.
Tarka 180 mg / 2 mg, bilayer tablet:
Each bilayer tablet contains 180 mg verapamil hydrochloride and 2 mg
trandolapril.
Excipient: Each 2 mg/180 mg bilayer tablet contains up to 108.625 mg
lactose (as lactose
monohydrate).
Tarka 240 mg / 4 mg, bilayer tablet:
Each bilayer tablet contains 240 mg verapamil hydrochloride and 4 mg
trandolapril.
Excipient: Each 4 mg/240 mg bilayer tablet contains 110.37 mg lactose
(as lactose
monohydrate).
For the full list of excipients, see List of excipients section.
PHARMACEUTICAL FORM
Tarka 180 mg / 2 mg, bilayer tablet:
Please see local registration
Tarka 240 mg / 4 mg, bilayer tablet:
Please see local registration
CLINICAL PARTICULARS
THERAPEUTIC INDICATIONS
Tarka is indicated for the treatment of essential hypertension in
patients whose blood pressure
has been normalized with the individual components in the same
proportion of doses or in
patients whose blood pressure is not adequately controlled on
trandolapril or verapamil alone.
POSOLOGY AND METHOD OF ADMINISTRATION
For oral use
Posology
_Adults:_
The usual dosage is one tablet or capsule daily.
SPECIAL POPULATIONS
_Pediatric population:_
The safety and efficacy of Tarka in children and adolescents have not
yet been established.
Trandolapril - Verapamil
SOLID 1000311530
v9.0
COMPANY CORE DATA
SHEET
TRANDOLAPRIL/VERAPAMIL
Date of approval: 24-Sep-2014
Date of previous approval: 14-Jan-2014
Abbott
Confidential information
2/28
This information is confidential
Therefore use in this age group is no